Tell Your Smartphone Where It Hurts: New App Intuitively Tracks Pain

Patient-provided data can help doctors and health care professionals gain a more complete picture on pain. See how the technology works.

7:00 AM

Author | Greta Guest

Patients with chronic pain have a new resource when it comes to answering the question: "On a scale of zero to 10, how much does it hurt?"

GeoPain, an app developed by a University of Michigan startup, is designed to help.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

By providing a 3D image of the body, the app lets users "paint" their pain on anatomically accurate models to help identify the location and intensity of discomfort and provide a more objective measurement of pain.

Patients can input factors such as symptoms, triggers and treatments over time for a more comprehensive review.

The aim: to track, analyze and communicate details that might be lost or misinterpreted with existing pain assessment methods.

"We can dissect the pain with greater precision, in one patient or several, and across multiple body locations," says Alexandre DaSilva, D.D.S., D.Med.Sc., an associate professor and director of the Headache & Orofacial Pain Effort Lab at the U-M School of Dentistry. He is also co-founder of MoxyTech, the startup that created GeoPain.

"Whether the patient has a migraine, fibromyalgia or dental pain, we can measure whether a particular medication or clinical procedure is effective for each localized or spread pain condition," DaSilva adds. "GeoPain is a GPS for pain health care."

The free app can be downloaded via Google Play or Apple's App Store and at GeoPain.com. It may be used on a smartphone or tablet.

Connectivity yields benefits

Beyond giving patients greater control of their pain story, the app could disrupt the way drug trials are conducted.

Increased precision and decreased variability of the reporting of pain has potential benefits for pharmaceutical manufacturers. Clinical trials could result in a better understanding of the efficacy of a drug while reducing both the number of patients and time to reach a conclusion.

MORE FROM THE LAB: Subscribe to our weekly newsletter

Initial studies at U-M showed that user-generated GeoPain measurements directly correlated with opioid activity in the brains of chronic pain patients. The app also outperformed traditional measures in complexity and speed by precisely mapping and detecting significant regional changes in pain relief.

"We expect it to revolutionize pain treatment," says Eric Maslowski, co-founder and chief technology officer of MoxyTech.

And it offers another tool for precision health. GeoPain users can record pain details between appointments to build a comprehensive record to share with a doctor. That record also can integrate with a hospital or pain clinic's cloud systems and devices. 

"Connected care to patients is a huge technological goal of ours, as is the exchange of pain information with proper permissions and controls," DaSilva says. "Such integrated analytics at patient or population levels would allow us more efficient development and precise evaluation of therapies for pain that chronically affects 100 million adults in the U.S. alone."

The app was created to track pain in patients from DaSilva's brain research and clinical trials in migraine and chronic pain at U-M, many funded by the National Institutes of Health. Several of the research studies involving GeoPain were recently presented at the World Congress on Pain conference in Boston.

[W]e can measure whether a particular medication or clinical procedure is effective for each localized or spread pain condition.
Alexandre DaSilva, D.D.S., D.Med.Sc.

Breaking the mold

Gender diversity is another important concept embraced by the GeoPain team, as patients can choose male or female 3D body representations. MoxyTech is also developing pediatric models.

"We want to break the mold," DaSilva says. "All pain matters to us."

SEE ALSO: App Guides Breast Cancer Patients Through Treatment

MoxyTech licensed the technology from the university and then worked with the U-M Office of Technology Transfer to optimize the app for the business sector. The company plans to market the app's data analytics to clinicians, health care systems and pharmaceutical companies for use in developing better treatments for pain.

GeoPain is also being tested at several clinics in Michigan with positive feedback.

"Patients appreciate the ability to color in their pain pattern on the tablet," says Tiziano Marovino, DPT, a clinical research physical therapist and practitioner at Chronic Pain Solutions in Ypsilanti, Michigan. "They are more aware of pain location, nature, intensity, duration and frequency. This appears to increase self-efficacy by providing a greater sense of control over their pain."

That sentiment could have a big payoff by prompting GeoPain users to be more active in their care.

"Instead of trying to recall pain during a visit with their physician, patients can record the intensity and location of their pain as it occurs," says Lynn Johnson, Ph.D., a professor at the U-M Dental School. "This has never been possible before."


More Articles About: Health Tech Health Care Quality Emerging Technologies chronic pain
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories zoom screens with 7 different backgrounds and doctor silhouettes outlined in each
Health Lab
The doctor is in…. but what’s behind them?
A study reveals that what a doctor has behind them during a telehealth visit can make a difference in how the patient feels about them and their care.
cancer cell blue yellow
Health Lab
Widening inequality seen where cancer clinical trials are available
The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Cannabis and psychedelics: stigmatized substances or powerful therapeutics?
Today on The Fundamentals is Dr. Kevin Boehnke, research assistant professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. His current research focuses on therapeutic applications of cannabis and psychedelics. His goal is to rigorously assess appropriate use of these substances and to help address the public health harms caused by their criminalization.
The Fundamentals Podcast Hero Card Final 1800 x 1350
The Fundamentals
Addiction is a lifelong disease and not a moral failing
On today’s The Fundamentals is Dr. Brummett, Professor at the University of Michigan where he serves as the Senior Associate Chair for Research in the Department of Anesthesiology. He has more than 280 publications, including articles in top journals such as JAMA, JAMA Surgery, Anesthesiology, and Annals of Surgery. He is the Co-Director of the Opioid Prescribing Engagement Network or OPEN at the University of Michigan, which aims to apply a preventative approach to the opioid epidemic in the US through appropriate prescribing after surgery, dentistry and emergency medicine. Moreover, he is the Co-Director of the cross-campus Opioid Research Institute, which was launched in the spring of 2023. He leads multiple NIH grants studying these concepts and receives funding from the Michigan Department of Health and Human Services, SAMHSA, CDC, and multiple foundations. You can learn more about Dr. Brummett here, and you can follow Dr. Brummett @drchadb and the department of anesthesiology @UMichAnesthesia on X.
Health Lab Podcast in brackets with a background with a dark blue translucent layers over cells
Health Lab Podcast
Study Shows Medical Marijuana Use Decreased in States with Legalized Recreational Use
The number of patients using cannabis for medical purposes has increased more than 600 percent since 2016.
Illustration of hand holding a smartphone with green background
Health Lab
Medicare pays for message-based e-visits. Are older adults using them?
Telehealth study of patient portal e-visits by Medicare participants shows few had an interaction for which their provider billed them.